Eris Lifesciences Ltd
Company Profile
Business description
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include LNBloc, Olmin, Eritel, Atorsave and Crevast. Geographically, the company generates key revenue from India followed by International markets operations spanning in Latin America, Africa, Asia-Pacific, the Middle East, and CIS regions.
Contact
Ramdas Road
Plot No. 142/2, Shivarth Ambit
Off SBR, Near Swati Bungalows
Bodakdev
AhmedabadGJ380054
INDT: +91 7969661000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3,076
Stocks News & Analysis
stocks
Do AI labs like Anthropic and OpenAI have economic moats?
stocks
12 picks for an income portfolio - Q3 2026 update
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,937.00 | 59.30 | 0.67% |
| CAC 40 | 7,823.17 | 19.84 | 0.25% |
| DAX 40 | 25,258.98 | 171.71 | 0.68% |
| Dow JONES (US) | 51,884.16 | 229.21 | 0.44% |
| FTSE 100 | 10,641.20 | 89.15 | 0.84% |
| HKSE | 24,271.20 | 59.85 | 0.25% |
| NASDAQ | 27,293.79 | 72.38 | -0.26% |
| Nikkei 225 | 69,030.92 | 11.19 | -0.02% |
| NZX 50 Index | 13,827.62 | 78.27 | 0.57% |
| S&P 500 | 7,810.54 | 1.00 | -0.01% |
| S&P/ASX 200 | 8,783.20 | 66.60 | 0.76% |
| SSE Composite Index | 3,797.24 | 16.55 | -0.43% |